Description
Kobe 2602 is an inhibitor of Ras that exhibits anticancer chemotherapeutic activities. In vitro, this compound inhibits cell growth and induces apoptosis and in vivo, it decreases tumor growth.
Product Unit Size | Cost | Quantity | Stock |
---|
Kobe 2602 is an inhibitor of Ras that exhibits anticancer chemotherapeutic activities. In vitro, this compound inhibits cell growth and induces apoptosis and in vivo, it decreases tumor growth.
Cas No. | 454453-49-7 |
---|---|
Purity | ≥98% |
Formula | C14H9F4N5O4S |
Formula Wt. | 419.31 |
Chemical Name | 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide |
IUPAC Name | 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide |
Synonym | 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide |
Solubility | DMSO: 15 mg/mL |
Appearance | Light yellow solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Shima F, Yoshikawa Y, Ye M, et al. In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8182-7. PMID: 23630290.
Shima F, Yoshikawa Y, Matsumoto S, et al. Discovery of small-molecule Ras inhibitors that display antitumor activity by interfering with Ras·GTP-effector interaction. Enzymes. 2013;34 Pt. B:1-23. PMID: 25034098.
Induces cardiomyogenic effects in pluripotent c...
Endogenous thyroid hormone T4.
Btk inhibitor.
Histamine H2 antagonist.
5-HT3 antagonist.
V600E B-Raf inhibitor.
Purine nucleotide analog, mercaptiopurine prodr...
Viral M2 proton channel blocker.
Azoxy compound
DPP4 inhibitor.
Read-through agent and nonsense mutation target...
EP4 receptor antagonist
Mixture of Ginkgolides A, B and C, found in Gin...
S-enantiomer of citalopram; SERT inhibitor.
Diterpene found in brewed, unfiltered coffee; F...
ACE inhibitor.
SIRT 1 activator, SIRT3 inhibitor.
Non-specific caspase inhibitor used to prevent ...
NSAID; COX-2 inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...